ArticleTechnology in cancer research & treatment
ReRNet: A Deep Learning Network for Classifying Blood Cells.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Novel Applications of Artificial Intelligence in Cancer Research.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
aimsBlood cell classification helps detect various diseases. However, the current classification model of blood cells cannot always get great results. A network that automatically classifies blood cells can provide doctors with data as one of the criteria for diagnosing patients' disease types and severity. If doctors diagnose blood cells, doctors could spend lots of time on the diagnosis. The diagnosis progress is very tedious. Doctors can make some mistakes when they feel tired. On the other hand, different doctors may have different points on the same patient.
methodsWe propose a ResNet50-based ensemble of randomized neural networks (ReRNet) for blood cell classification. ResNet50 is used as the backbone model for feature extraction. The extracted features are fed to 3 randomized neural networks (RNNs): Schmidt neural network, extreme learning machine, and dRVFL. The outputs of the ReRNet are the ensemble of these 3 RNNs based on the majority voting mechanism. The 5 × 5-fold cross-validation is applied to validate the proposed network.
resultsThe average-accuracy, average-sensitivity, average-precision, and average-F1-score are 99.97%, 99.96%, 99.98%, and 99.97%, respectively.
conclusionsThe ReRNet is compared with 4 state-of-the-art methods and achieves the best classification performance. The ReRNet is an effective method for blood cell classification based on these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.